Srp-9001-305
ClinicalTrials.gov NCT05967351
Research payments
$2,613,087
Through program year 2025, $2,613,087 in research payments was reported against Srp-9001-305, across 1,829 payments, paid by Sarepta Therapeutics, Inc..
- Paid by
- Sarepta Therapeutics, Inc.
- ClinicalTrials.gov
- NCT05967351
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,325,373 | 1,046 |
| 2024 | Research | $1,285,838 | 780 |
| 2023 | Research | $1,875 | 3 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Anne Connolly Columbus, OH Named on 398 payments
- Craig Zaidman Saint Louis, MO Named on 300 payments
- Craig McDonald Sacramento, CA Named on 142 payments
- Emma Ciafaloni Rochester, NY Named on 75 payments
- Crystal Proud Norfolk, VA Named on 71 payments
- Carmen Leon Astudillo Gainesville, FL Named on 70 payments
- Aravindhan Veerapandiyan Little Rock, AR Named on 58 payments
- Perry Shieh Los Angeles, CA Named on 48 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.